GlassScriptPhysician profile
Priyanka Bhat
NPI 1457909939
$1,492.35
in general payments reported to CMS, 2019-2025
18 companies · $691 in 2025
The $691 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $170 · 2024: $632 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,341.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $302.20 | 2024-2025 | Arikayce, Brinsupri |
| Abiomed | $212.22 | 2024-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $184.79 | 2024-2025 | Airsupra, Fasenra, Farxiga |
| Merck Sharp & Dohme LLC | $144.04 | 2024-2025 | Winrevair, Keytruda, Recarbrio |
| Grifols USA, LLC | $70.27 | 2024-2025 | Prolastin-C Liquid |
| La Jolla Pharmaceutical Company | $67.30 | 2024-2025 | Giapreza |
| Stryker Corporation | $48.88 | 2025 | Flowtriever |
| Pfizer INC. | $39.13 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.32 | 2025 | Ofev |
| United Therapeutics Corporation | $36.72 | 2024-2025 | Tyvaso, Tyvaso |
| Alnylam Pharmaceuticals INC. | $36.67 | 2025 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $35.69 | 2025 | |
| Glaxosmithkline, LLC. | $33.01 | 2024 | Nucala, Trelegy Ellipta, Arexvy |
| Vital Connect, INC | $26.01 | 2025 | Vitalpatch Rtm |
| Jazz Pharmaceuticals INC. | $19.01 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $16.97 | 2025 | Opsumit, Uptravi |
| Csl Behring | $16.51 | 2025 | Kcentra |
| Philips North America LLC | $14.96 | 2024 | (Ak6) Vest Therapy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priyanka Bhat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.